Differences in duration of Huntington's disease based on age at onset

被引:152
|
作者
Foroud, T [1 ]
Gray, J [1 ]
Ivashina, J [1 ]
Conneally, PM [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
来源
关键词
Huntington's disease; duration; age at onset;
D O I
10.1136/jnnp.66.1.52
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives-Data from a sample of 2494 patients affected with Huntington's disease (HD), collected as part of the National Research Roster for Huntington Disease Patients and Families, were examined to determine if there was a relation between age at onset and duration of illness. Methods-Sufficient data for inclusion in analysis was available from 2068 patients, of whom 828 were deceased and 1240 were living. The median duration of disease was 21.4 years with a range of 1.2 to 40.8 years. Patients were categorised into one of four groups based on their age at onset. Results-Significant differences in duration based on the age at onset were found (p<0.025), with juvenile and late onset patients with HD having shorter duration of illness compared with those with an onset between 20-49 years. Conclusions-Duration of disease is influenced by the age at symptom onset with juvenile and late onset patients having the shortest duration.
引用
收藏
页码:52 / 56
页数:5
相关论文
共 50 条
  • [31] Cognitive and psychiatric features of Huntington's disease patients in relation to age at disease onset
    Paridi, D
    Albanese, A
    Genitrini, S
    Mariotti, C
    Di Donato, S
    Girotti, F
    Soliveri, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [32] Do demographic and clinical factors modulate age of onset in Huntington's disease?
    Peavy, Guerry M.
    Goldstein, Jody L.
    Jacobson, Mark W.
    Wasserman, Linda M.
    Corey-Bloom, Jody
    NEUROLOGY, 2007, 68 (12) : A229 - A229
  • [33] Death of neuronal clusters contributes to variance of age at onset in Huntington's disease
    Cajavec, B
    Herzel, H
    Bernard, S
    NEUROGENETICS, 2006, 7 (01) : 21 - 25
  • [34] Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation
    Chen, SM
    Ferrone, FA
    Wetzel, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) : 11884 - 11889
  • [35] Mendelian randomization study of coffee consumption and age at onset of Huntington's disease
    Wang, Mengmeng
    Cornelis, Marilyn C.
    Zhang, Zhizhong
    Liu, Dandan
    Lian, Xuegan
    CLINICAL NUTRITION, 2021, 40 (11) : 5615 - 5618
  • [36] Death of neuronal clusters contributes to variance of age at onset in Huntington’s disease
    Branka Čajavec
    Hanspeter Herzel
    Samuel Bernard
    Neurogenetics, 2006, 7 : 21 - 25
  • [37] Clinical and genetic characterization of Huntington's disease in relation to the age and type of onset
    Mendoza Vega, L.
    Rodriguez-Violante, M.
    Cervantes-Arriaga, A.
    De-la-Cruz-Landero, A.
    Davila-Avila, N.
    Salinas-Barboza, K.
    Isais-Millan, S.
    MOVEMENT DISORDERS, 2017, 32
  • [38] A model to predict the onset age in unaffected Huntington's disease mutation carriers
    Squitieri, F
    Gellera, C
    Ruggieri, S
    Castellotti, B
    Frontali, M
    Mandich, P
    Nacmias, B
    Del Senno, L
    Ragona, G
    Di Donato, P
    Ajmar, F
    Frati, L
    Novelletto, A
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 457 - 457
  • [39] Standardizing the CAP Score in Huntington's Disease by Predicting Age-at-Onset
    Warner, John H.
    Long, Jeffrey D.
    Mills, James A.
    Langbehn, Douglas R.
    Ware, Jennifer
    Mohan, Amrita
    Sampaio, Cristina
    JOURNAL OF HUNTINGTONS DISEASE, 2022, 11 (02) : 153 - 171
  • [40] An ADORA2A polymorphism modifies age at onset in Huntington's disease
    Burnouf, S.
    Dhaenens, C-M
    Simonin, C.
    Vanbrussel, E.
    Duhamel, A.
    Defebvre, L.
    Duru, C.
    Vuillaume, I.
    Cazeneuve, C.
    Charles, P.
    Maison, P.
    Debruxelles, S.
    Verny, C.
    Gervais, H.
    Azulay, J-P
    Tranchant, C.
    Bachoud-Levi, A-C
    Duerr, A.
    Buee, L.
    Sablonniere, B.
    Blum, D.
    Krystkowiak, P.
    MOVEMENT DISORDERS, 2009, 24 : S166 - S167